Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.

Denzin LK, Khan AA, Virdis F, Wilks J, Kane M, Beilinson HA, Dikiy S, Case LK, Roopenian D, Witkowski M, Chervonsky AV, Golovkina TV.

Immunity. 2017 Aug 15;47(2):310-322.e7. doi: 10.1016/j.immuni.2017.07.013.

2.

Corrigendum: TCRα-TCRβ pairing controls recognition of CD1d and directs the development of adipose NKT cells.

Vieth JA, Das J, Ranaivoson FM, Comoletti D, Denzin LK, Sant'Angelo DB.

Nat Immunol. 2017 Jul 19;18(8):951. doi: 10.1038/ni0817-951a. No abstract available.

PMID:
28722718
3.

TCRα-TCRβ pairing controls recognition of CD1d and directs the development of adipose NKT cells.

Vieth JA, Das J, Ranaivoson FM, Comoletti D, Denzin LK, Sant'Angelo DB.

Nat Immunol. 2017 Jan;18(1):36-44. doi: 10.1038/ni.3622. Epub 2016 Nov 21. Erratum in: Nat Immunol. 2017 Jul 19;18(8):951.

PMID:
27869818
4.

Update on Gender Equity in Immunology, 2001 to 2016.

Shapiro VS, Kovats S, Parent MA, Gaffen SL, Hedrick CC, Jain P, Denzin LK, Raghavan M, Stephens R.

J Immunol. 2016 Nov 15;197(10):3751-3753. Epub 2016 Oct 17.

5.

Cretaceous collegiality.

Eisenlohr LC, Denzin LK.

Mol Immunol. 2015 Dec;68(2 Pt A):67. doi: 10.1016/j.molimm.2015.08.013. Epub 2015 Sep 8. No abstract available.

PMID:
26359187
6.

Zbtb16 (PLZF) is stably suppressed and not inducible in non-innate T cells via T cell receptor-mediated signaling.

Zhang S, Laouar A, Denzin LK, Sant'Angelo DB.

Sci Rep. 2015 Jul 16;5:12113. doi: 10.1038/srep12113.

7.

Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.

Denzin LK.

Front Immunol. 2013 Dec 17;4:465. doi: 10.3389/fimmu.2013.00465. Review.

8.

HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.

Pezeshki AM, Azar GA, Mourad W, Routy JP, Boulassel MR, Denzin LK, Thibodeau J.

Hum Immunol. 2013 Oct;74(10):1280-7. doi: 10.1016/j.humimm.2013.05.010. Epub 2013 Jun 10.

PMID:
23756162
9.

Sibling rivalry: competition between MHC class II family members inhibits immunity.

Denzin LK, Cresswell P.

Nat Struct Mol Biol. 2013 Jan;20(1):7-10. doi: 10.1038/nsmb.2484.

PMID:
23288359
10.

TLR agonists downregulate H2-O in CD8alpha- dendritic cells.

Porter GW, Yi W, Denzin LK.

J Immunol. 2011 Oct 15;187(8):4151-60. doi: 10.4049/jimmunol.1003137. Epub 2011 Sep 14.

11.

The Paf oncogene is essential for hematopoietic stem cell function and development.

Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH, Moore MA, Park CY, Sant'Angelo DB, Denzin LK.

J Exp Med. 2011 Aug 29;208(9):1757-65. doi: 10.1084/jem.20102170. Epub 2011 Aug 15.

12.

H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers.

Draghi NA, Denzin LK.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16607-12. doi: 10.1073/pnas.1004664107. Epub 2010 Aug 31.

13.

Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.

Yi W, Seth NP, Martillotti T, Wucherpfennig KW, Sant'Angelo DB, Denzin LK.

J Clin Invest. 2010 Apr;120(4):1324-36. doi: 10.1172/JCI40220.

14.

Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta.

Deshaies F, Diallo DA, Fortin JS, O'Rourke HM, Pezeshki AM, Bellemare-Pelletier A, Raby N, Bédard N, Brunet A, Denzin LK, Thibodeau J.

Immunology. 2009 Jul;127(3):408-17. doi: 10.1111/j.1365-2567.2008.02984.x. Epub 2008 Nov 14.

15.

Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function.

Fallas JL, Yi W, Draghi NA, O'Rourke HM, Denzin LK.

J Immunol. 2007 Feb 1;178(3):1488-97.

17.

Right place, right time, right peptide: DO keeps DM focused.

Denzin LK, Fallas JL, Prendes M, Yi W.

Immunol Rev. 2005 Oct;207:279-92. Review.

PMID:
16181343
18.

Dipping into the cytosol to broaden the MHC class II peptide repertoire.

Denzin LK, Sant'angelo DB.

Immunity. 2005 May;22(5):536-7. No abstract available.

19.

A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Deshaies F, Brunet A, Diallo DA, Denzin LK, Samaan A, Thibodeau J.

Proc Natl Acad Sci U S A. 2005 May 3;102(18):6443-8. Epub 2005 Apr 22.

20.

Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.

Fallas JL, Tobin HM, Lou O, Guo D, Sant'Angelo DB, Denzin LK.

J Immunol. 2004 Aug 1;173(3):1549-60.

21.

Comparison of the transcriptional regulation of classical and non-classical MHC class II genes.

Hake SB, Tobin HM, Steimle V, Denzin LK.

Eur J Immunol. 2003 Sep;33(9):2361-71.

22.

Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Tolosa E, Li W, Yasuda Y, Wienhold W, Denzin LK, Lautwein A, Driessen C, Schnorrer P, Weber E, Stevanovic S, Kurek R, Melms A, Bromme D.

J Clin Invest. 2003 Aug;112(4):517-26.

23.

Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.

Sant'Angelo DB, Robinson E, Janeway CA Jr, Denzin LK.

Eur J Immunol. 2002 Sep;32(9):2510-20.

24.

Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO.

Glazier KS, Hake SB, Tobin HM, Chadburn A, Schattner EJ, Denzin LK.

J Exp Med. 2002 Apr 15;195(8):1063-9. Erratum in: J Exp Med. 2003 Dec 1;198(11):1765.

25.

Maintenance of TCR clonality in T cells expressing genes for two TCR heterodimers.

Sant'Angelo DB, Cresswell P, Janeway CA Jr, Denzin LK.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6824-9. Epub 2001 May 29.

26.

The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.

Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P.

J Immunol. 1998 Oct 1;161(7):3282-91.

27.

Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.

Chervonsky AV, Medzhitov RM, Denzin LK, Barlow AK, Rudensky AY, Janeway CA Jr.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10094-9.

28.

Quantitative defect in staphylococcal enterotoxin A binding and presentation by HLA-DM-deficient T2.Ak cells corrected by transfection of HLA-DM genes.

Albert LJ, Denzin LK, Ghumman B, Bangia N, Cresswell P, Watts TH.

Cell Immunol. 1998 Jan 10;183(1):42-51.

PMID:
9578718
29.

Negative regulation by HLA-DO of MHC class II-restricted antigen processing.

Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P.

Science. 1997 Oct 3;278(5335):106-9.

30.
31.

HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments.

Pierre P, Denzin LK, Hammond C, Drake JR, Amigorena S, Cresswell P, Mellman I.

Immunity. 1996 Mar;4(3):229-39.

32.

Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM.

Robbins NF, Hammond C, Denzin LK, Pan M, Cresswell P.

Hum Immunol. 1996 Jan;45(1):13-23.

PMID:
8655355
33.
34.

Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells.

Denzin LK, Robbins NF, Carboy-Newcomb C, Cresswell P.

Immunity. 1994 Oct;1(7):595-606.

PMID:
7600288
35.

Mutational analysis of active site contact residues in anti-fluorescein monoclonal antibody 4-4-20.

Denzin LK, Gulliver GA, Voss EW Jr.

Mol Immunol. 1993 Oct;30(15):1331-45.

PMID:
8232321
36.

Elicitation of distinct populations of monoclonal antibodies specific for the variable domains of monoclonal anti-fluorescein antibody 4-4-20.

Weidner KM, Denzin LK, Kim ML, Mallender WD, Miklasz SD, Voss EW Jr.

Mol Immunol. 1993 Aug;30(11):1003-11.

PMID:
8350870
37.

Construction, characterization, and selected site-specific mutagenesis of an anti-single-stranded DNA single-chain autoantibody.

Rumbley CA, Denzin LK, Yantz L, Tetin SY, Voss EW Jr.

J Biol Chem. 1993 Jun 25;268(18):13667-74.

38.

Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives.

Tetin SYu, Mantulin WW, Denzin LK, Weidner KM, Voss EW Jr.

Biochemistry. 1992 Dec 8;31(48):12029-34.

PMID:
1457402
39.

Molecular stabilization effects of interactions between anti-metatype antibodies and liganded antibody.

Weidner KM, Denzin LK, Voss EW Jr.

J Biol Chem. 1992 May 25;267(15):10281-8.

40.

Characterization of a single-chain T-cell receptor expressed in Escherichia coli.

Hoo WF, Lacy MJ, Denzin LK, Voss EW Jr, Hardman KD, Kranz DM.

Proc Natl Acad Sci U S A. 1992 May 15;89(10):4759-63.

41.
42.

Importance of dynamic properties of idiotopes in interactions with anti-Id antibodies.

Voss EW Jr, Weidner KM, Denzin LK.

Immunol Invest. 1992 Feb;21(1):71-83. Review.

PMID:
1548048
43.

Autologous anti-metatype immune response in rabbits.

Voss EW Jr, Moore JK, Weidner-McGufficke KM, Denzin LK, Bedzyk WD, Voss VH.

Mol Immunol. 1992 Feb;29(2):241-9.

PMID:
1542300
44.
45.

Immunological and structural characterization of a high affinity anti-fluorescein single-chain antibody.

Bedzyk WD, Weidner KM, Denzin LK, Johnson LS, Hardman KD, Pantoliano MW, Asel ED, Voss EW Jr.

J Biol Chem. 1990 Oct 25;265(30):18615-20.

Supplemental Content

Loading ...
Support Center